These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Computed tomography-guided percutaneous cryoablation and microwave ablation in the treatment of perivascular hepatocellular carcinoma: A comparative study with propensity score matching. Li B, Ren ZW, Zhang C, Yu XX, Xu XX, Du Y, Yang HF. Clin Res Hepatol Gastroenterol; 2024 Mar; 48(3):102298. PubMed ID: 38367802 [Abstract] [Full Text] [Related]
43. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study. Wang C, Liao Y, Qiu J, Yuan Y, Zhang Y, Li K, Zou R, Wang Y, Zuo D, He W, Zheng Y, Li B, Yuan Y. J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005 [Abstract] [Full Text] [Related]
49. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a propensity score matching analysis. Jin T, Liu X, Zhang H, Cao Y, Dai C, Tang S, Xu F. Int J Hyperthermia; 2020 Oct; 37(1):955-964. PubMed ID: 32781862 [Abstract] [Full Text] [Related]
51. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis. Feng Y, Wang L, Lv H, Shi T, Xu C, Zheng H, Qi J, Zhao X, Li J, Gao Y, Qin C, Zhu Q. HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089 [Abstract] [Full Text] [Related]
52. Severity of cirrhosis should determine the operative modality for patients with early hepatocellular carcinoma and compensated liver function. Huang ZY, Liang BY, Xiong M, Dong KS, Zhang ZY, Zhang EL, Li CH, Chen XP. Surgery; 2016 Feb; 159(2):621-31. PubMed ID: 26453137 [Abstract] [Full Text] [Related]
54. Hepatic resection versus operative microwave ablation for single hepatocellular carcinoma ≤5 cm: A propensity score-matched analysis. Ryu T, Takami Y, Wada Y, Hara T, Sasaki S, Saitsu H. Surgery; 2019 Sep; 166(3):254-262. PubMed ID: 31279438 [Abstract] [Full Text] [Related]
55. Combined hepatectomy and microwave ablation for multifocal hepatocellular carcinoma: Long-term outcomes and prognostic factors. Ryu T, Takami Y, Wada Y, Sasaki S, Imamura H, Ureshino H, Saitsu H. Asian J Surg; 2021 Jan; 44(1):186-191. PubMed ID: 32473893 [Abstract] [Full Text] [Related]
56. Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis. Gupta P, Maralakunte M, Kumar-M P, Chandel K, Chaluvashetty SB, Bhujade H, Kalra N, Sandhu MS. Eur Radiol; 2021 Jul; 31(7):5400-5408. PubMed ID: 33439319 [Abstract] [Full Text] [Related]
57. Microwave ablation shows similar survival outcomes compared with surgical resection for hepatocellular carcinoma between 3 and 5 cm. Zheng H, Xu C, Wang X, Li J, Zhao X, Qi J, Feng Y, Zhu Q. Int J Hyperthermia; 2020 Nov 12; 37(1):1345-1353. PubMed ID: 33289415 [Abstract] [Full Text] [Related]
58. Laparoscopic liver resection is superior to radiofrequency ablation for small hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched studies. Chen W, Lin X, Wu Z, Pan W, Ke Q, Chen Y. Hepatol Int; 2024 Jun 12; 18(3):998-1010. PubMed ID: 38480604 [Abstract] [Full Text] [Related]
60. Long-term efficacy and safety of microwave ablation for hepatocellular carcinoma adjacent to the gallbladder with a diameter ≤ 5 cm: a multicenter, propensity score matching study. Li L, Yao J, Yan X, Qi X, Liang P, Han Z, Liu F, Cheng Z, Luo Y, Zheng R, Cheng W, Wei Q, Yu S, Yu J, Yu X. Int J Hyperthermia; 2023 Jun 12; 40(1):2248425. PubMed ID: 37607775 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]